Alliancebernstein L.P. Enanta Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 29,940 shares of ENTA stock, worth $279,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,940

Previous 29,940 -0.0%

Holding current value

$279,639

Previous $388,000 20.1%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.43 - $17.02 $22,974 - $34,210	2,010 Added 7.2%	29,940 $388,000
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $22,413 - $29,537	-2,740 Reduced 8.93%	27,930 $262,000
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $93,821 - $187,219	8,460 Added 38.09%	30,670 $342,000
Q2 2023 Aug 15, 2023	BUY	$20.68 - $39.85 $55,215 - $106,399	2,670 Added 13.66%	22,210 $475,000
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $111,607 - $156,946	-2,875 Reduced 12.83%	19,540 $790,000
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $1.17 Million - $1.54 Million	-28,614 Reduced 56.07%	22,415 $1.04 Million
Q3 2022 Nov 15, 2022	SELL	$48.29 - $71.27 $3.63 Million - $5.36 Million	-75,175 Reduced 59.57%	51,029 $2.65 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $590,061 - $1.19 Million	15,475 Added 13.98%	126,204 $5.97 Million
Q1 2022 May 13, 2022	BUY	$56.06 - $74.11 $2.85 Million - $3.77 Million	50,875 Added 85.0%	110,729 $7.88 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $2.2 Million - $3.56 Million	36,604 Added 157.44%	59,854 $4.48 Million
Q3 2021 Nov 10, 2021	SELL	$41.02 - $58.65 $98,448 - $140,760	-2,400 Reduced 9.36%	23,250 $1.32 Million
Q1 2021 May 06, 2021	BUY	$41.69 - $54.95 $3,335 - $4,396	80 Added 0.31%	25,650 $1.27 Million
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $154,795 - $191,102	-3,570 Reduced 12.25%	25,570 $1.17 Million
Q4 2019 Feb 18, 2020	SELL	$57.95 - $66.61 $1.28 Million - $1.48 Million	-22,160 Reduced 43.2%	29,140 $1.8 Million
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $180,240 - $264,510	-3,000 Reduced 5.52%	51,300 $3.08 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $707,310 - $846,945	8,700 Added 19.08%	54,300 $4.58 Million
Q4 2018 Feb 13, 2019	BUY	$65.41 - $84.65 $115,775 - $149,830	1,770 Added 4.04%	45,600 $3.23 Million
Q3 2018 Nov 08, 2018	BUY	$85.46 - $126.37 $213,649 - $315,925	2,500 Added 6.05%	43,830 $3.75 Million
Q2 2018 Aug 13, 2018	BUY	$81.85 - $120.51 $499,284 - $735,111	6,100 Added 17.31%	41,330 $4.79 Million
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $2.72 Million - $4.33 Million	-47,030 Reduced 57.17%	35,230 $2.85 Million
Q4 2017 Feb 13, 2018	SELL	$45.65 - $59.37 $450,109 - $585,388	-9,860 Reduced 10.7%	82,260 $4.83 Million
Q3 2017 Nov 13, 2017	BUY	$37.91 - $46.8 $3.49 Million - $4.31 Million	92,120	92,120 $4.31 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Enanta Pharmaceuticals Inc Transaction History